| Approved? (Admin-only) |
|
|---|---|
| Opportunity Type | Funding Opportunity Announcement (FOA) |
| Funding Opportunity Posted By | DOD |
| Component | DHA - CDMRP |
| Funding Opportunity Title | CDMRP Vision Research Program (VRP) |
| Opportunity ID | HT942526VRPIIRA, HT942526VRPCTA, HT942526VRPMCRA, HT942526VRPTRA |
| Link to Funding Opportunity | ebrap.org |
| Funding Opportunity Short Description | Vision Research Program (VRP) |
| Funding Opportunity Category | Health and Biomedical Technologies |
| Important Dates | |
| Open Date | 05/06/2026 |
| White Paper / Pre-Proposal / Solution Summary Due | 07/28/2026 |
| Full Applications Due | 09/10/2026 |
| Funding Details | |
| Funding Mechanism |
|
| Eligibility |
|
| Assistance Listings | 12.420 -- Military Medical Research and Development |
| Required Registrations |
|
| Funding Opportunity Full Description | The fiscal year 2026 (FY26) Vision Research Program (VRP) Investigator-Initiated Research Award (IIRA) supports basic through early translational research that will yield highly impactful discoveries or major advancements in the research and/or patient care of eye injury and/or visual dysfunction related to military exposure. The IIRA may be used to support preclinical studies and/or clinical research. Research must align with at least one of the FY26 VRP Focus Areas. The IIRA cannot be used to support clinical trials. The fiscal year 2026 (FY26) Vision Research Program (VRP) Clinical Trial Award (CTA) supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of service-connected eye injury and visual dysfunction. Research must align with at least one of the FY26 VRP Focus Areas. The fiscal year 2026 (FY26) Vision Research Program (VRP) Mentored Clinical Research Award (MCRA) supports patient-oriented vision injury research conducted by highly motivated military or civilian clinicians in training. The MCRA may be used to support a standalone study of high impact to vision injury care or the generation of clinical research data in preparation for a more expansive study. Research must align with at least one of the FY26 VRP Focus Areas. The MCRA may not be used to support preclinical research or clinical trials. The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial, but not a full-scale clinical trial. Research must align with at least one of the FY26 VRP Focus Areas. |
